Modus Therapeutics raises approximately SEK 28.3 million

The two companies have announced a strategic collaboration to advance next-generation biotherapeutics, they state.

Neogap Therapeutics has been awarded a SEK 1 million grant from Vinnova to initiate a collaborative project with Weill Cornell Medicine in New York, US.

Moberg Pharma has entered into an exclusive licensing agreement with Karo Healthcare regarding the commercialization of MOB-015 (Terclara) in Europe.

The FDA has issued a complete response letter (CRL) for Alvotech’s Biologics License Application (BLA) for AVT05, in a prefilled syringe and autoinjector presentations, a biosimilar candidate to Simponi (golimumab).

Sound Bioventures has joined the company's investor syndicate with a SEK 34 million investment.

Through the deployment of ChatGPT Enterprise to its global workforce, Lundbeck will empower employees with AI capabilities designed to accelerate discovery, enhance decision-making, and drive unprecedented efficiency, it states.

The collaboration marks a significant milestone for AAX Biotech, underscoring the potential of its Opti-mAb technology for innovative antibody therapeutics, it states.